Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for Dyspnea in Cancer Patients
NCT03367156Phase 2Active, not recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Dec 2017
- Primary completion
- May 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone in Dyspnea, sponsored by University of Texas MD Anderson Cancer Center. Started Dec 2017; status: active, not recruiting.
02
Drugs
dexamethasone
03
Conditions
Dyspnea
Beyond the preview
Go deeper on NCT03367156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03367156.